Skip to content
Screener

Viatris VTRS Other operating expenses

Other operating expenses at other companies

McKesson logo
McKessonMCK
$2.37B+5.5%
AMP
Amphastar PharmaceuticalsAMPH
$53.74M+21.3%
ARS Pharmaceuticals, Inc. logo
ARS Pharmaceuticals, Inc.SPRY
$82.83M+83.4%
Amneal Pharmaceuticals, Inc. logo
Amneal Pharmaceuticals, Inc.AMRX
$1.3M
Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
-1.1%

Other financials

Income statement

See full
Revenue$3.8B+4.9%
Gross profit$1.5B+9.3%
Operating income$6.3M-97.3%
Net income-$118.8M-2,483%
EPS (diluted)-$0.10

Balance sheet

See full
Cash & equivalents$890.0M+56.7%
Total debt$13.6B-7.7%
Total equity$14.3B-8.4%
Total assets$35.0B-8.8%

Cash flow

See full
Operating cash flow$381.8M+73.8%
CapEx$52.8M-0.2%
Free cash flow$329.0M+97.2%

Valuation

See full
Market cap$20.55B+100%
Enterprise value$33.29B+36.1%
P/S1.4×+0.7×

Profitability

See full
Gross margin34.8%-1.8pp
Operating margin-0.6%
Net margin-2.8%-1.3pp
FCF margin13.3%+0.9pp

Returns & leverage

See full
Return on equity-2.8%-1.3pp
Debt / equity0.0×
Current ratio1.6×+0.2×

Where this comes from

Reported directly by Viatris in its filing.

Tagged under the XBRL concept us-gaap:OperatingExpenses.

The source filing: Viatris’s 10-Q, filed August 6, 2026.

Filed
Aug 6, 2026, 4:04 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001792044-26-000041
Line itemThree Months Ended / June 30, 2026Three Months Ended / June 30, 2025Six Months Ended / June 30, 2026Six Months Ended / June 30, 2025
Selling, general and administrative1,134.5928.72,063.31,876.8
Impairment of goodwill2,936.8
Litigation settlements and other contingencies, net73.2(47.6)126.7(121.1)
Total operating expenses1,450.21,099.92,687.15,143.3
Earnings (loss) from operations6.3233.0(73.4)(2,649.2)
Interest expense120.7116.6240.8232.1
Other (income) expense, net(50.4)333.5(2.9)432.8
Loss before income taxes(64.0)(217.1)(311.3)(3,314.1)

ITEM 6. [Exhibits](#i61e5533529bd4b8b8b580f5cad6a41ec_190) [74](#i61e5533529bd4b8b8b580f5cad6a41ec_190)

FAQ

What is Viatris's other operating expenses?
Viatris (VTRS) reported other operating expenses of $1.45B in Q2 2026.
How has Viatris's other operating expenses changed year-over-year?
Viatris's other operating expenses increased by 31.8% year-over-year, from $1.1B to $1.45B.
What is the long-term trend for Viatris's other operating expenses?
Over 4 years (2021 to 2025), Viatris's other operating expenses has grown at a 8.2% compound annual growth rate (CAGR), from $5.61B to $7.68B.
What does other operating expenses mean?
Residual operating expenses not classified into specific categories, serving as a catch-all for miscellaneous operating costs.

Ask your AI about Viatris's other operating expenses.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude